Alerts will be sent to your verified email
Verify Email
SAMRATPH
|
Samrat Pharmachem
|
Asston Pharma
|
Amwill Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.86 % | 31.69 % | 84.18 % |
|
5yr average Equity Multiplier
|
1.83 | 5.73 | 0.32 |
|
5yr Average Asset Turnover Ratio
|
2.61 | 0.79 | 2.35 |
|
5yr Avg Net Profit Margin
|
3.87 % | 10.83 % | 13.8 % |
|
Price to Book
|
1.1 | 7.18 | 1.18 |
|
P/E
|
49.88 | 17.77 | 7.6 |
|
5yr Avg Cash Conversion Cycle
|
58.79 Days | 121.8 Days | 115.9 Days |
|
Inventory Days
|
28.98 Days | 31.3 Days | 26.46 Days |
|
Days Receivable
|
80.32 Days | 296.65 Days | 133.46 Days |
|
Days Payable
|
46.76 Days | 343.23 Days | 129.03 Days |
|
5yr Average Interest Coverage Ratio
|
16.47 | 3.57 | 0.0 |
|
5yr Avg ROCE
|
27.43 % | 42.37 % | 102.76 % |
|
5yr Avg Operating Profit Margin
|
5.58 % | 15.11 % | 17.69 % |
|
5 yr average Debt to Equity
|
0.21 | 1.99 | 0.0 |
|
5yr CAGR Net Profit
|
5.93 % | 108.46 % | 33.09 % |
|
5yr Average Return on Assets
|
10.3 % | 7.75 % | 26.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.09 % | 50.66 % | 70.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.45 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Samrat Pharmachem
|
Asston Pharma
|
Amwill Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|